The extracellular N-terminus of G-protein-coupled receptors may be involved in signalling events. We examined this in the angiotensin II type 1 receptor (AT1-R) using monoclonal antibody 6313/G2, raised against a conserved sequence in the N-terminal domain, and found it evokes inhibitory and stimulatory responses. In rat aortic smooth muscle cell (RASMC) primary cultures, 6313/G2 (2 . 5 mg/ml) inhibited both basal and angiotensin II (Ang II; 10
Introduction
Vascular smooth muscle cell (VSMC) growth (hyperplasia/ hypertrophy) occurs in chronic vascular diseases including atherosclerosis and hypertension. Angiotensin II (Ang II), produced by the renin-angiotensin system (RAS), plays a crucial role in the VSMC proliferative activity (Berk 2001 , Cheng et al. 2005 . In addition to the systemic RAS, local tissue RASs may also be involved with VSMC growth (Berk 2001 , Xiao et al. 2004 , Kobori et al. 2007 . For these reasons, the RAS is a key target for drugs combating cardiovascular disease (Weir & Dzau 1999) . The actions of angiotensinconverting enzyme inhibitors and Ang II type 1 receptor (AT1-R) blockers are well studied (Bohm 2007) . There is still scope for development, however, and one view is that targeting the RAS by gene therapy or antibody (Cheng et al. 2005 ) treatment may provide a longer term treatment for hypertension (Leckie 2005 , Oro et al. 2007 .
The AT1 receptor is a member of the G-protein-coupled receptor superfamily (Griendling & Alexander 1993) and has been shown to mediate most of the physiological actions of Ang II (Higuchi et al. 2007) . Although the ligand-binding region of AT1-R is generally thought to be partly in the barrel formed by the seven transmembrane domains (Griendling & Alexander 1993 , Correa et al. 2002 , Perodin et al. 2002 , and also to involve extracellular domains, including part of the N-terminal region (Hjorth et al. 1994 , Santos et al. 2004 , Pignatari et al. 2006 , Oliveira et al. 2007 and there is now a growing body of evidence that suggests that the N-terminus undergoes activation-dependent conformational changes and influences receptor activity (Hjorth et al. 1994 , Lecat et al. 2002 , Motta et al. 2003 , Gupta et al. 2007 . However, relatively little is known about the N-terminus-mediated signalling pathways.
Through interactions with AT1-R and phospholipase C activation, Ang II triggers the inositol trisphosphate (IP 3 )/ calcium and the protein kinase C (PKC) signalling pathways (Malarkey et al. 1996) . Of the 12 distinct members of the PKC family (Mellor & Parker 1998) , which all exhibit distinct properties and activation profiles (Mellor & Parker 1998) , PKCa is the major Ca 2C -dependent phorbol-ester-sensitive PKC in neonatal rat ventricular myocytes (Puceat et al. 1994) and after phosphorylation it has been shown to inhibit cell proliferation (Acs et al. 1997) . Although other members of the PKC family are involved in mitogenic signal transduction (Toker 1998 ), the precise mechanism is still not clear, though one common route is by activating the mitogen-activated protein (MAP) kinases through multiple mechanisms, including increased extracellular signal-regulated kinases (ERK1/2) phosphorylation (Toker 1998 , Heidkamp et al. 2001 , Daniels et al. 2007 .
The MAP kinase superfamily of serine/threonine protein kinases is associated with the increased expression of the early response genes c-fos, c-myc and c-jun (Lyall et al. 1992) , DNA synthesis and cell growth (Morrell et al. 1999) . In cultured VSMC and in intact arteries, Ang II activates ERK1/2, c-Jun N-terminal kinases (JNKs) and p38 that are the three major members of the MAP kinase family, via AT1-R (Touyz et al. 1999) , and although their exact functional effects are ill-defined, regulation of cell proliferation may be an important result of ERK1/2 activation (Touyz & Schiffrin 2000) . Downstream activator protein-1 (AP-1) consisting of a variety of dimers composed of members of the Fos, Jun and activating transcription factor (ATF) families of proteins (Angel & Karin 1991) convert extracellular signals into changes in the expression of specific targets which harbour AP-1-binding site(s) in their promoter or enhancer regions. Among factors regulating AP-1 are the ERK cascade that induces hyperphosphorylation of Fos and increases its activity, as well as JNKs that phosphorylate Jun and ATF within their N-terminal transactivation domains and enhance their transactivation potential (Wagner 2001) . AP-1 family members regulate cell proliferation and differentiation in the context of both normal development and disease (Hess et al. 2004) .
Our previous results showed that a monoclonal antibody (6313/G2) to be a conserved sequence in the extracellular domain of the AT1-R stimulates IP 3 and aldosterone production, while non-competitively inhibiting Ang II-induced PKC activation (Kapas et al. 1994) . The present studies were designed to explore action of this antibody on the proliferation of rat arterial smooth muscle cells (RASMCs). Understanding the relationship between the structure and functions of this receptor could lead to novel therapies in chronic vascular diseases. Anti-phospho-PKCa (Ser657) and anti-PKCa were purchased from Upstate Ltd (Milton Keynes, UK). Anti-AT1-R monoclonal antibody (6313/G2, mouse IgG subclass 2a, hybridoma supernatant) was produced as previously described (Barker et al. 1993) and purified using ImmunoPure(L) Immunoglobulin Purification Kit from Perbio Science UK Ltd (Cramlington, UK) according to the manufacturer's protocol. The purified 6313/G2 was used for all experiments, except both purified 6313/G2 and 6313/G2 hybridoma supernatant were used in the cell proliferation and 6313/G2 specificity studies. Unless otherwise stated, all other reagents were purchased from Sigma.
Materials and Methods

Materials
Cell culture
RASMCs were isolated from rat thoracic and abdominal arteries by the media explant method and cultured over several passages according to previously described methods (Xiao et al. 2004) . RASMCs were grown in RPMI-1640 culture medium supplemented with 100 units/ml penicillin, 100 mg/ml streptomycin, 4 mmol/l L-glutamine and 20% FBS. Cultures were incubated at 37 8C in a humidified atmosphere of 5% CO 2 in air. Cells were passaged using a solution of 0 . 125% trypsin and 0 . 02% EDTA in PBS. Experiments were performed after three to five passages. Stimulants added as appropriate were Ang II and bFGF (basic fibroblast growth factor) and the specific AT1R inhibitor losartan was also used (generously given by Merck Sharp & Dohme Ltd).
Tritiated thymidine uptake
A suspension of RASMC (10 5 cells/ml) was prepared on the first day of the experiment using RPMI-1640 supplemented with 20% FBS. The cells were synchronised in the G 0 /G 1 phase by serum deprivation for 24 h. The quiescent (serumdeprived) cells were incubated with the appropriate experimental media in the presence of 2% FBS for 48 h with four wells per group. Methyl-[ 3 H]thymidine (0 . 1 mCi/ml) in 10 ml medium was added to each well, which contained 1 ml medium/well. After 24 h of the addition of radioactive thymidine 20 nM, cells were collected as described previously (Xiao et al. 2004) . Cells were then dissolved in 0 . 5 ml of 0 . 1 M NaOH and a 0 . 3 ml aliquot was mixed with 3 . 5 ml scintillation fluid (Packard Instrument BV Chemical Operations, Groningen, The Netherlands) and, after standing overnight at room temperature, tritium content was assayed in a liquid scintillation counter.
Cell count
A suspension of RASMC (0 . 5!10 5 cells/ml) was prepared on the first day of the experiment using RPMI-1640 supplemented with 20% FBS. One millilitre of this cell suspension was distributed to each well of a 24-well multiwell dish. The medium was replaced 24 h after the subculture with appropriate experimental media with three wells per group.
Experiments were terminated after an additional 48-h incubation. The cells were resuspended by washing them with PBS and treatment with 0 . 3 ml PBS containing 0 . 125% trypsin and 0 . 02% EDTA. Digestion was stopped by the addition of 0 . 7 ml of 20% FBS RPMI-1640 to each well.
Cells were counted in a haemocytometer using light microscopy.
Immunoblotting analysis
Sample preparations Cultured cells were treated with Ang II at 10 K7 mol/l for 1, 5, 10, 20, 30 and 60 min to examine the effects of Ang II on phosphorylations of PKCa and ERK1/2. The short-term (10 min) and long-term (48 h) effects of 6313/G2 on activities of ERK1/2 and PKCa were carried out by incubating these cells with purified 6313/G2 at 2 . 5 mg/ml, or as negative control with mouse non-specific IgG (whole molecule, unconjugate) from Perbio Science UK Ltd. Solubilised total cell protein from cultured cells was prepared as described previously (Xiao et al. 2000) , and the membrane fraction was extracted using a Compartmental Protein Extraction kit (CHEMICON Europe Ltd, Eastleigh, Hampshire, UK). Extracted protein was estimated using DC Protein Assay (Bio-Rad).
SDS-PAGE Unless otherwise stated, 50 mg/lane protein was separated on 9% SDS-PAGE to identify the activation of ERK1/2 and 30 mg/lane on 7 . 4% SDS-PAGE to examine the activation of PKCa. Proteins were separated on SDS-PAGE together with Precision Protein Standard (Bio-Rad) and transferred to Hybond-ECL nitrocellulose membrane (Amersham Biosciences) overnight at 30 V at 4 8C. Membranes were blocked in 5% non-fat dry milk in Tris-buffered saline with Tween-20 (TBS-T; 20 mM Tris base, 150 mM NaCl and 0 . 1% Tween-20, pH 7 . 6) for 2 h at room temperature followed by incubation with diluted 1:1000 rabbit monoclonal anti-phospho-p44/42 ERK1/2 antibodies and/or rabbit polyclonal anti-p44/42 ERK1/2 antibodies, in TBS-T with 5% BSA, or with diluted 1:1000 rabbit polyclonal anti-phospho-PKCa (Ser657) antibody and/or mouse anti-PKCa monoclonal antibody in TBS-T at 4 8C with gentle shaking overnight. To test specificities of purified 6313/G2 and 6313/G2 hybridoma supernatant, membrane protein amounts ranging from 2 . 5 to 40 mg were used, and membranes with transferred proteins were incubated with unpurified 6313/G2 undiluted supernatant or purified antibody, 2 . 5 mg/ml, at 4 8C overnight. In another experiment, serial dilutions of 6313/G2 supernatant were used with a fixed concentration of membrane protein (30 mg per lane).
Detection of protein Protein-bound antibody was detected by incubation of the membrane with horseradish peroxidase-labelled second antibody at room temperature for 1 . 5 h. Conjugated donkey anti-rabbit IgG (Amersham Biosciences) diluted 1:2000 in TBS-T was used for detection of anti-phospho-ERK1/2/anti-ERK1/2 antibody and anti-phospho-PKCa and sheep anti-mouse IgG (1:1000) was used to detect anti-PKCa and 6313/G2. Bands were detected using enhanced chemiluminescence assay reagents and quantified by Image Acquisition and Analysis software (UVP, Cambridge, UK).
Measurement of [Ca 2C ] i in RASMC
RASMCs cultured on ultrathin glass coverslips were loaded with 1 mM Fura-2 acetoxymethyl ester in serum-free RPMI-1640 medium for 30 min at 37 8C in a humidified atmosphere of 5% CO 2 in air. The cells were then washed three times using modified Krebs-Ringer bicarbonate solution (3 . 6 mM Transient transfection-AP1 reporter assay pAP1(PMA)-TA-Luc is designed for monitoring the induction of the PKC signal transduction pathway, as well as related pathways such as the MAP kinase pathway, by assaying luciferase activity. pAP1(PMA)-TA-Luc contains six tandem copies of AP1 enhancer, located upstream of the sense encoding firefly luciferase (Luc). Transfections and luciferase assays were conducted using TransFast Transfection Reagent and Dual-Luciferase Reporter Assay System, according to the manufacturer's protocol. Briefly, cells were prepared as for the thymidine incorporation experiments. Cells, cultured in 24-well dishes with serum-free culture medium, were transiently transfected with 0 . 5 mg pAP1(PMA)-TA-Luc. As a control for transfection efficiency, samples were cotransfectedwith 0 . 25 mg pCVM-b-gal. After 3-h incubation at 37 8C, serum-free culture medium was replaced with 20% FBS culture medium. After 12 h of transfection, cells were washed with PBS and then incubated in the absence or presence of Ang II at 10 K7 mol/l and/or purified 6313/G2, 2 . 5 mg/ml, in 2% FBS culture medium for 24 h. Luciferase assays were performed using a Luminoskan microplate luminometer and Ascent Software (ThermoLabsystems, Helsinki, Finland), and b-galactosidase was assayed using standard procedures (Smith et al. 2001) .
Statistical analysis
Values are expressed as meansGS.E.M. The level of significance for difference between means was evaluated by ANOVA and Student's t-test.
Results
Cell proliferation
Tritiated thymidine incorporation into RASMC was significantly increased by Ang II (10 K7 mol/l) in 2% FBS medium compared with controls, but this was inhibited by purified 6313/G2 (2 . 5 mg/ml). 6313/G2 added alone to RASMC also significantly decreased tritiated thymidine incorporation when compared with controls (Fig. 1A) . Similar results were obtained from treatment with unpurified 6313/G2 hybridoma supernatant diluted 1:10 in culture medium (Fig. 1B) .
Using cell counts as measure of proliferation (Fig. 1C) , Ang II again stimulated proliferation, and this was inhibited by losartan 10 K5 mol/l (P!0 . 01). Cell number was also increased by bFGF (50 ng/ml; P!0 . 05), but bFGF stimulation was blocked by neither losartan nor 6313/G2.
Immunoblotting
Both purified and unpurified 6313/G2 showed linear reactivity in immunoblots of serially diluted membrane proteins ( Fig. 2A and B) and there was also a linear relationship with dilutions of antibody (Fig. 2C) . In all cases, 6313/G2 recognised a single discrete protein band of approximate molecular weight 60 kDa.
Phosphorylated ERK1/2 and total ERK1/2 with molecular weights of 44 and 42 kDa and phosphorylated PKCa and total PKCa with a molecular weight of 82 kDa were detected by immunoblot analysis in RASMC incubated with or without 6313/G2 (2 . 5 mg/ml) or Ang II (10 K7 mol/l) in 2% FBS medium for 10 min and 48 h (Fig. 3) . Treatment with 6313/G2 significantly inhibited phosphorylation of ERK1/2 and increased phosphorylation of PKCa, compared with controls. As negative controls, non-specific IgG treatment gave no changes in either phosphorylated ERK1/2 or phosphorylated PKCa in short-term treatment. Conversely, immunoblotting for phosphorylated ERK1/2 and PKCa demonstrated that although Ang II induced rapid (1-5 min) activation of ERK1/2 (data not shown) it had no sustained effect on ERK1/2 phosphorylation. It also had no effects on PKCa phosphorylation nor on total ERK1/2 and PKCa protein.
Measurement of intracellular Ca
2C
Transient elevation of intracellular Ca 2C by 6313/G2 (2 . 5 mg/ml; Fig. 4A and C) and Ang II (10 K7 mol/l; Fig. 4B and D) was detected in cultured RASMC. Figure 4A and B shows pseudocolour images of cultured RASMC measured by ratiometry of Fura-2. After 10 s of stimulation, [Ca 2C ] i increased in these cells. The effects of 6313/G2 and Ang II on [Ca 2C ] i dynamics are different. The ratio of Figure 3 (A) RASMCs were incubated alone or treated with purified 6313/G2 (2 . 5 mg/ml), Ang II 10 K7 mol/l, and/or non-specific IgG (2 . 5 mg/ml) in 2% FBS RPMI-1640 medium for 10 min (short term) and 48 h (long term). Two phospho-ERK bands with the expected sizes of 44 and 42 kDa and a specific band with the expected size of 82 kDa for phospho-PKCa were detected, and both used for quantitation. (B) Quantification of phosphorylated proteins shows treatment with 6313/G2 significantly decreased ERK1/2 phosphorylation and increased PKCa phosphorylation in short-and long-term treatment, and Ang II had no such sustained effect. As negative controls, non-specific IgG had no effects on the phosphorylation of ERK1/2 and PKCa in short treatment. Data are meansGS.E.M. from three experiments. Values are expressed as a percentage of control values. Student's t-test: **P!0 . 01 and * P!0 . 05 versus control culture. C, control culture; Ab, purified 6313/G2; Ang, Ang II and IgG, non-specific IgG.
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Journal of Endocrinology (2008) 197, 25-33 fluorescence intensities, F340/F380 (Fig. 4C and D) , shows that Ang II gave a single peak at 19 s, whereas 6313/G2 invariably showed two peaks at 12 s and a larger subsequent peak at 25 s. A non-specific IgG control gave no response (not shown).
AP-1 reporter assay
When cultured RASMCs were transfected with vector pAP1(PMA)-TA-Luc, treatment with Ang II (10 K7 mol/l) enhanced luciferase activity compared with controls (Fig. 5 ), but this enhancement was not inhibited by 6313/G2 (2 . 5 mg/ml). In contrast, 6313/G2 alone added to RASMC significantly decreased luciferase activity when compared with controls.
Discussion
Monoclonal antibody 6313/G2 recognises AT1R with high specificity (Harrison-Bernard et al. 1997 , Yang et al. 1997 , Cheng et al. 2005 . Immunoblots from most target tissues show a single immunoreactive band, though of varying molecular weight, apparently because of differences in degrees of glycosylation. Cells that do not express the receptor are not immunoactive (Barker et al. 1993) . The high specificity of 6313/G2 was confirmed by the single 60 kDa immunoreactive band detected in RASMC membrane proteins, regardless of antibody or membrane protein concentration, or indeed antibody purity, over the concentration range used (Fig. 2) . The molecular weight is significantly higher than predicted by the primary structure of the receptor, but consistent with other results, and probably reflects the degree of glycosylation (Barker et al. 1993) .
Many studies have examined Ang II-induced mitogenic effects in cultured RASMC and their inhibition by the AT1-R antagonist losartan (Weber et al. 1994 , Xiao et al. 2000 . Monoclonal antibody 6313/G2, whether used in an unpurified or purified form, was also effective in inhibiting Ang II-stimulated RASMC proliferation (Fig. 1) . A number of studies, including our own (Xiao et al. 2000) , have demonstrated the autocrine function of Ang II in cultured VSMC, which may explain the inhibition of 6313/G2 on basal cell proliferation in the absence of Ang II (Fig. 1A and B) . We can additionally confirm that AT1 receptor inhibition by losartan, the specific AT1-R antagonist, also produces inhibition of cell proliferation in the absence of any added stimulation (data not shown).
Although it is known that AT1-R signals crosstalk with other receptors, for example, the a-adrenergic or endothelin, so that part of the actions of these ligands are mediated by AT1-R (Cook et al. 1993 , Dzimiri 2002 , Lemos et al. 2002 , Nossaman et al. 2007 , Wang et al. 2007 , in these experiments, bFGF-stimulated proliferation was blocked by neither losartan nor 6313/G2 (Fig. 1C) , demonstrating its independence of AT1-R signalling, again supporting the specificity of 6313/G2's action.
The intracellular signalling evoked by the AT1-R has been extensively studied in VSMC (Higuchi et al. 2007) . Ang II elicits complex highly regulated cascades of intracellular signal transduction that lead to short-term (seconds or minutes) vascular effects, such as contraction, and to long-term (hours or days) effects, such as cell growth, migration, extracellular matrix deposition and inflammation (Touyz & Schiffrin 2000) . Ang II-stimulated long-term effects are mediated via activation of various kinases, including MAP kinase, induction of proto-oncogene expression and stimulation of nuclear signalling cascades, ultimately resulting in cellular growth (Touyz & Schiffrin 2000) . To understand whether the MAP kinases were involved in the inhibitory effects of 6313/G2, their activation was assessed by immunoblot analysis in treated RASMC. The data demonstrate that 6313/G2 caused a reduction in the level of phosphorylated ERK1/2 (Fig. 3) in RASMC after 10-min and 48-h exposure to 6313/G2, without any effect on total p44/42 ERK1/2, whereas non-specific IgG had no effect. These data may appear consistent with the inhibition by 6313/G2 of Ang II-stimulated cell proliferation. In contrast, as others have shown (Morrell et al. 1999) , Ang II itself induced a transient activation of ERK1/2 at 2-5 m (data not shown) but had no effect at longer periods (Fig. 3) .
The mechanisms underlying AT1-mediated MAP kinase responses are related to amplification by PKCs (Malarkey et al. 1996 , Oro et al. 2007 . In myocytes, PKC isoenzymes are differentially activated by various stimuli (Clerk et al. 1994 , Puceat et al. 1994 , Strait & Samarel 2000 and PKCs differently regulate MAP kinase cascades in an isoenzymespecific and time-dependent manner (Heidkamp et al. 2001) . Previously, we showed that 6313/G2 alters Ang II-induced PKC localisation in rat-dispersed adrenal glomerulosa cells (Kapas et al. 1994) . However, in the present study, 6313/G2 rapidly induced phosphorylation of PKCa and this was sustained over 48 h (Fig. 3) . This is perhaps consistent with inhibition of proliferation, as others have suggested (Acs et al. 1997) . In contrast, Ang II had no such long-term effect on PKCa phosphorylation (Fig. 3) . In RASMC, ERK1/2 is activated by PKC3 (Malarkey et al. 1996) and by PKC z (Berra et al. 1995) , which lack the C2 domain, thus their kinase activities are Ca 2C independent (Liao et al. 1997) . It is relevant that PKCa is calcium activated (Toker 1998) , though its interactions with ERK1/2 (Seo et al. 2004) , and indeed cell hypertrophy/proliferation remains unclear (Stewart & O'Brian 2005) .
The integrated Ca 2C signal stimulated by Ang II is complex and elicited via multiple pathways, including release from calcium stores and calcium channel activation (Touyz & Schiffrin 2000) . Our studies demonstrated that 6313/G2 also induced a transient Ca 2C signal response in RASMC (Fig. 4 ) and it is possible that this Ca 2C transient triggered the increased phosphorylation of PKCa. Interestingly, the Ca 2C signal from 6313/G2, with two peaks, differs from that evoked by Ang II (Fig. 4) , suggesting different kinetics of Ca 2C release or entry. Many of the signal events relevant to cell proliferation are mediated through activation of AP-1, by the MAP kinase family, and these have also been shown to be activated by interactions of Ang II and AT1-R (Ishida et al. 1998) . It is believed that Ang II rapidly increases the DNA-binding activity of AP-1 in RASMC through activation of JNKs (Viedt et al. 2000) . Our results confirmed that 6313/G2 Figure 5 Effect of 6313/G2 on Ang II-induced AP-1 promoter activity. After transfection with 0 . 5 mg vector pAP1(PMA)-TA-Luc, RASMCs were treated with purified 6313/G2 (2 . 5 mg/ml), or Ang II inhibited basal activity of the AP-1 reporter, but had no effect on Ang II-stimulated activation of AP-1 (Fig. 5) , perhaps indicating that this antibody exerts inhibitory effects on AP-1 activity via an alternative route. Downregulation of ERK1/2 (Fig. 3 ) may contribute to 6313/G2-mediated inhibition of AP-1 activity, whereas, as noted, Ang II activates AP-1.
In total, the results show that in RASMC, as in the rat adrenal (Kapas et al. 1994) , 6313/G2 has unique actions on AT1 receptor-linked signalling pathways. It exerts inhibitory effects on RASMC growth perhaps through increased phosphorylation of PKCa, decreased ERK1/2 activation and inhibition of AP-1 activity, but in contrast it also produces a calcium signal. These properties are somewhat different from those described for agonist antibodies in pre-eclampsia (Thway et al. 2004) , and suggest that antibodies raised against different receptor domains might evoke different activities, though such studies have not been done. Furthermore, such discriminatory effects on intracellular signalling may indicate new routes for therapy in atherosclerosis and hypertension.
